Leukocyte low density lipoprotein receptor (LDL-R) does not contribute to LDL clearance in vivo: bone marrow transplantation studies in the mouse
- PMID: 9162757
Leukocyte low density lipoprotein receptor (LDL-R) does not contribute to LDL clearance in vivo: bone marrow transplantation studies in the mouse
Abstract
The _targeted disruption of the low density lipoprotein (LDL) receptor gene in mice results in accumulation of plasma LDL cholesterol and in predisposition to diet-induced aortic atherosclerosis. Although the liver is the central organ for receptor mediated clearance of LDL, the in vivo role of other organs and tissues in LDL catabolism has not been directly studied. Since bone marrow-derived cells such as blood leukocytes and tissue macrophages express LDL receptors and contribute a large mass to the body, we designed bone marrow transplantation (BMT) experiments to reconstitute LDL receptor null mice [LDL-R(-/-)] with marrow obtained from LDL-R wild-type mice [LDL-R(+/+)] and evaluate the effects on parameters of plasma lipid metabolism. Although reconstitution of the transplanted mice with donor bone marrow cells was complete, no differences in plasma lipid levels and lipoprotein distribution were found between groups, irrespective of the diet used, and turnover studies using 125I-labeled LDL showed that LDL receptor expression by leukocytes and macrophages does not significantly contribute to plasma LDL clearance. The complementary experiment of transplanting LDL-R(-/-) marrow into C57BL/6 recipients [LDL-R(-/-)-->LDL(+/+)], performed to evaluate the role of leukocyte LDL-R in normocholesterolemic condition, also produced no effects on plasma lipid parameters. LDL binding studies using macrophages isolated from transplanted mice showed a lack of LDL-R expression. Thus, despite their large number and wide distribution, bone marrow-derived cells do not significantly influence receptor-mediated clearance of plasma LDL.
Similar articles
-
Effect of bone marrow transplantation on lipoprotein metabolism and atherosclerosis in LDL receptor-knockout mice.Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):1995-2003. doi: 10.1161/01.atv.17.10.1995. Arterioscler Thromb Vasc Biol. 1997. PMID: 9351364
-
Role of leukocyte-specific LDL receptors on plasma lipoprotein cholesterol and atherosclerosis in mice.Arterioscler Thromb Vasc Biol. 1997 Feb;17(2):340-7. doi: 10.1161/01.atv.17.2.340. Arterioscler Thromb Vasc Biol. 1997. PMID: 9081690
-
Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knockout mice.J Lipid Res. 2000 Sep;41(9):1402-9. J Lipid Res. 2000. PMID: 10974047
-
Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice.Cardiovasc Res. 2007 Oct 1;76(1):175-83. doi: 10.1016/j.cardiores.2007.05.016. Epub 2007 May 17. Cardiovasc Res. 2007. PMID: 17560559
-
Macrophages, lipoprotein metabolism, and atherosclerosis: insights from murine bone marrow transplantation studies.Curr Opin Lipidol. 1999 Apr;10(2):97-105. doi: 10.1097/00041433-199904000-00003. Curr Opin Lipidol. 1999. PMID: 10327277 Review.
Cited by
-
Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice.Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):174-9. doi: 10.1161/01.ATV.0000148548.47755.22. Epub 2004 Oct 21. Arterioscler Thromb Vasc Biol. 2005. PMID: 15499039 Free PMC article.
-
Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation.Am J Pathol. 1998 Dec;153(6):1923-35. doi: 10.1016/S0002-9440(10)65706-9. Am J Pathol. 1998. PMID: 9846982 Free PMC article.
-
Rhinovirus inhibits IL-17A and the downstream immune responses in allergic asthma.Mucosal Immunol. 2016 Sep;9(5):1183-92. doi: 10.1038/mi.2015.130. Epub 2016 Jan 6. Mucosal Immunol. 2016. PMID: 26732679 Free PMC article. Clinical Trial.
-
Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.Circulation. 2004 Sep 14;110(11):1492-8. doi: 10.1161/01.CIR.0000141735.13202.B6. Epub 2004 Sep 7. Circulation. 2004. PMID: 15353487 Free PMC article.
-
Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia.Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1686-91. doi: 10.1161/01.atv.0000033090.81345.e6. Arterioscler Thromb Vasc Biol. 2002. PMID: 12377750 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases